XTX Topco’s 20/20 Biolabs Inc AIDX Stock Holding History

XTX Topco’s Portfolio AIDX Stock Details AIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,329	Closed	-$19.4K	–	4912
2026 Q1	$19.4K	Buy	+10,329	New	+$43.6K	﹤0.01%	3554

Other funds holding AIDX

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AUB

Atlantic Union Bankshares Glen Allen, Virginia $5.99B AUM 23.66% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

McDonald Partners Cleveland, Ohio $412M AUM 34.27% 1-Year Est. Return

XTX Topco's AIDX Position: Q2 2026 in Review

XTX Topco sold out of 20/20 Biolabs Inc (AIDX) in Q2 2026, closing a stake of 10,329 shares — an estimated $19.4K sold.

XTX Topco first reported a position in AIDX in Q1 2026 and held it in 1 quarter. The position peaked at $19.4K in Q1 2026. 15 funds tracked by Wall St. Rank hold AIDX as of Q2 2026.

XTX Topco reported no remaining 20/20 Biolabs Inc position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 10,329 20/20 Biolabs Inc shares in Q2 2026, an estimated $19.4K.
XTX Topco first reported a position in 20/20 Biolabs Inc in Q1 2026 and held it in 1 quarter.
XTX Topco's 20/20 Biolabs Inc position peaked at $19.4K in Q1 2026.
15 funds tracked by Wall St. Rank held 20/20 Biolabs Inc as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.